The lack of effect of myostatin inhibition on hyperglycemia in their study is in contrast to the current findings, and previous work using mouse models of obesity and lipodystrophy29, 30, 31, 32, 33 (including studies authored by the same group [31, 32]). This evidence concerns the gene MSTN and obesity disorder.